Filter
930
Text search:
isoniazid
Featured
109
268
Language
Document type
733
86
52
27
10
9
6
4
3
Countries / Regions
49
37
34
30
28
27
27
23
19
19
18
18
17
14
14
14
13
12
10
9
9
9
9
8
7
7
7
7
7
5
5
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
361
105
21
16
15
9
7
Toolboxes
406
137
32
18
13
12
9
8
8
3
2
2
2
1
1
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evi
...
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for is
...
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat
...
HIV/TB Research Meeting; March 3, 2013
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
Профілактичне лікування ізоніазидом. Що це таке?
